SCHEMBL1938013

SCHEMBL1938013

CCC/C=C/CC(=O)Nc1ccccc1NC(=O)OC(C)(C)C

nearest known ligand 0.44

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 4/20 0.41
MAPK1 P28482 1/20 0.40
CNR2 P34972 1/20 0.40
HTT P42858 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
RXFP1 Q9HBX9 1/20 0.39
LMNA P02545 1/20 0.39
POLB P06746 1/20 0.39
CTSK P43235 2/20 0.38
BRD9 Q9H8M2 1/20 0.38
KMT2A Q03164 1/20 0.38
ALDH1A1 P00352 1/20 0.37
HPGD P15428 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1938014 1.00 HDAC3 (0.41) HDAC3MAPK1CNR2HTTSMN1; SMN2
SCHEMBL1937844 0.90 HDAC3 (0.41) HDAC3HTTSMN1; SMN2RXFP1LMNA
SCHEMBL1937843 0.90 HDAC3 (0.41) HDAC3HTTSMN1; SMN2RXFP1LMNA
SCHEMBL1937882 0.89 HDAC3 (0.46) HDAC3HTTSMN1; SMN2RXFP1LMNA
SCHEMBL1937883 0.89 HDAC3 (0.46) HDAC3HTTSMN1; SMN2RXFP1LMNA
SCHEMBL1937956 0.83 HDAC3 (0.37) HDAC3HTTSMN1; SMN2RXFP1LMNA
SCHEMBL1938430 0.83 HDAC3 (0.37) HDAC3CNR2HTTSMN1; SMN2RXFP1
SCHEMBL1938431 0.83 HDAC3 (0.37) HDAC3CNR2HTTSMN1; SMN2RXFP1
SCHEMBL1937955 0.83 HDAC3 (0.37) HDAC3HTTSMN1; SMN2RXFP1LMNA
SCHEMBL1938578 0.83 HDAC3 (0.65) HDAC3SMN1; SMN2LMNAPOLBCTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2330894-A1 COMPOSITIONS INCLUDING 6-AMINOHEXANOIC ACID DERIVATIVES AS HDAC INHIBITORS REPLIGEN CORPORATION (US) 2011-06-15 EP disclosed
WO-2010028192-A1 COMPOSITIONS INCLUDING 6-AMINOHEXANOIC ACID DERIVATIVES AS HDAC INHIBITORS REPLIGEN CORPORATION (US) 2010-03-11 WO disclosed